Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 375,000 shares at $4.52 ($1.8M) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Scheduled sale ($1.8M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.52 | 125,000 | $565K | 32.1% |
| 2 | $4.80 | 125,000 | $600K | 34.0% |
| 3 | $4.78 | 125,000 | $598K | 33.9% |
| Total | $4.70 avg | 375,000 | $1.8M | 100% |
| Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |
| RLAY | SELL | 2025-11-04 | $435K | — | Filing → |